XML 33 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
OPERATING ACTIVITIES      
Net income (loss) $ (380.1) $ (437.5) $ 513.4
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Impairment, restructuring and other 288.6 666.8 0.0
Share-based compensation expense 68.9 34.3 40.6
Depreciation 67.3 68.1 62.9
Amortization 25.2 37.1 30.9
Deferred taxes (58.7) (182.8) 22.5
Equity in (income) loss of unconsolidated affiliates, net of distributions 101.1 12.9 (2.6)
Other, net 1.3 1.1 (10.8)
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable 77.7 102.8 15.5
Inventories 450.5 (203.8) (496.5)
Prepaid and other current assets 18.6 (3.3) (76.5)
Accounts payable (153.6) (171.2) 202.5
Other current liabilities 52.0 (68.4) (21.6)
Other non-current items (30.7) 20.1 (10.1)
Other, net 2.9 (5.2) 1.3
Net cash provided by (used in) operating activities 531.0 (129.0) 271.5
INVESTING ACTIVITIES      
Proceeds from sale of long-lived assets 2.5 63.3 0.2
Investments in property, plant and equipment (92.8) (113.5) (106.9)
Proceeds from loans receivable 37.0 0.0 0.0
Investments in unconsolidated affiliates 0.0 0.0 (102.3)
Payment for acquisitions, net of cash acquired 0.0 (237.3) (127.8)
Purchase of convertible debt investments 0.0 (25.0) (193.1)
Other investing, net (12.4) 29.3 (8.7)
Net cash used in investing activities (65.7) (283.2) (538.6)
FINANCING ACTIVITIES      
Borrowings under revolving and bank lines of credit and term loans 1,336.2 3,617.4 1,243.2
Repayments under revolving and bank lines of credit and term loans (1,689.8) (2,937.3) (1,361.5)
Financing and issuance fees (6.4) (9.6) (13.1)
Dividends paid (149.1) (166.2) (143.0)
Purchase of Common Shares (9.3) (257.9) (129.3)
Cash received from exercise of stock options 2.3 3.3 15.2
Acquisition of noncontrolling interests 0.0 0.0 (17.5)
Other financing, net (4.0) 5.6 0.0
Net cash (used in) provided by financing activities (520.1) 255.3 494.0
Effect of exchange rate changes on cash (0.1) (0.4) 0.6
Net increase (decrease) in cash and cash equivalents (54.9) (157.3) 227.5
Cash and cash equivalents at beginning of year 86.8 244.1 16.6
Cash and cash equivalents at end of year 31.9 86.8 244.1
Senior Notes due 2031 – 4.000%      
FINANCING ACTIVITIES      
Proceeds from Issuance of Senior Notes 0.0 0.0 500.0
Senior Notes due 2032 – 4.375%      
FINANCING ACTIVITIES      
Proceeds from Issuance of Senior Notes $ 0.0 $ 0.0 $ 400.0